The active compound is identical, but approval status and dosing limits differ
Given the recent influx of evidence suggesting a connection between the popular diabetes and weight loss drug, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and various ocular adverse events, a new study aimed to investigate this potential association on a global scale
Thats 1 out of 6 overall who had to stop taking it
The people who are at the highest risk of B12 insufficiency or deficiency are older adults, those with atrophic gastritis, gastrointestinal disorders, pernicious anemia, those who have had gastrointestinal surgery, vegans, and vegetarians
On licensing: REMEVi is licensed to provide care across all 50 states plus the District of Columbia full nationwide coverage